Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
3
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
clinical trials
detroit blog main
detroit top stories
3
×
indiana blog main
indiana top stories
johnson & johnson
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
aducanumab
affordable care act
alzheimer's disease
biotech
celgene
deals
eli lilly
gene therapy
gilead sciences
What
bio
news
3
×
roundup
biogen’s
drug
nash
aducanumab
alzheimer’s
amyloid
angst
approval
august
bagged
billions
biogen
biopharmaceutical
biotech
brammer
busy
companies
convo
days
decisions
devices
drugs
earlier
effects
failure
failures
fda
felt
legacy
littered
lost
new
nods
opioid
past
price
regulatory
Language
unset
Current search:
biogen
×
news
×
" detroit top stories "
×
@xconomy.com
5 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More